6505--Mesalamine 1200mg Tablet

The Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0025) for the supply of Mesalamine 1200mg enteric-coated, delayed-release tablets packaged in bottles of 120 tablets each. This unrestricted procurement will serve multiple federal healthcare entities, including the VA's Consolidated Mail Order Pharmacies, Department of Defense's Tricare Mail Order Pharmacies, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded to one responsible offeror capable of ensuring an uninterrupted supply, with a base period of one year and four one-year option periods. Distribution will be conducted via the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. Offerors must provide the drug under the exact label name and a unique National Drug Code (NDC) specific to them, ensuring that contractors cannot overlay labels but that VA labels can securely adhere to the existing label. The packaging must include a safety cap that can be converted to a non-safety form and meet specified size and labeling requirements. The solicitation will be issued electronically in commercial item format around May 25, 2026, with offers due by June 9, 2026. Estimated annual demand is approximately 107,364 bottles, each containing 120 tablets. All solicitation documents will be available on SAM.gov, with Youlanda Duggar serving as the primary point of contact for inquiries related to this procurement.